Biotech

All Articles

Lilly posts even more beneficial records on its own every week insulin prospect

.On the heels of an FDA denial for its own main rival Novo Nordisk, Eli Lilly is actually pulling ah...

IN 8bio stops period 2 test, gives up fifty percent of labor force

.Just a few months after dosing the very first person in a stage 2 test for newly identified gliobla...

Lilly, Haya ink $1B biobuck weight problems contract to search darker genome

.Eli Lilly's look for obesity targets has actually led it to the darker genome. The Big Pharma has p...

ArsenalBio raises $325M, rotates off of previous lead resource

.Arsenal Biosciences is carrying on up. The cell treatment business has added $325 thousand in ammun...

Lilly- supported effective weight loss biotech reports IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to deb...

Aelis' marijuana make use of medication fails stage 2b, steering Indivior to review $100M option

.Aelis Farma's chances of getting a simple, positive selection on a $100 million option remittance h...

ProKidney stops phase 3 trial not needed for tissue treatment authorization

.ProKidney has actually ceased some of a pair of phase 3 tests for its tissue treatment for kidney c...

Vaxcyte climbs on 'impressive' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what professionals named "sensational" phase 1/2 data for its own 31-valent pneumo...

Recursion's mind ailment test shows insufficient documentation of efficiency

.Recursion has stumbled by means of an early test of its own tech-enabled method to medicine discove...

Acepodia, Pfizer click with each other for chemistry-based cell therapy

.Call it a situation of really good chemical make up: Acepodia, a biotech based upon Nobel Champion ...